| Jun 25, 2013
| 12:26 PM
Ron Klein, a member of Holland & Knight's Public Policy & Regulation Group, has worked in the private sector as a business and transactional attorney for over 25 years, as well as the public sector as an elected official in both Tallahassee and...
| Feb 6, 2014
| 3:45 PM
WASHINGTON – The United States could be losing its edge in science and technology as emerging nations rapidly increase their investment in research and development, according to new indicators released Thursday by the National Science Board....
| Apr 15, 2014
| 4:15 PM
Newport News Shipbuilding and NASA Langley Research Center in Hampton are feeling the pinch of budget uncertainty in Washington, but Sen. Tim Kaine says Congress might clear that up in the coming weeks.
The Virginia Democrat toured both facilities...
| Jan 27, 2014
| 1:05 PM
WASHINGTON – The interim nuclear deal between Iran and world powers will allow Tehran to continue far more research and development on centrifuges to enrich uranium than has been publicly recognized, according to a veteran Washington nuclear...
| Dec 18, 2013
| 11:55 AM
Followers of Herbalife, the Los Angeles peddler of nutritional supplements, know it's actually two stories rolled into one.
One is the story of how a company with a questionable business model, overhyped products, and an almost invisible research and...
| Jan 3, 2014
| 6:25 AM
On a recent Friday evening, long after most workers had gone home, there were barely any parking spaces available outside a quiet South Windsor office complex.
Musicians, media-types and fans lined up outside the headquarters of Telefunken-...
| Jan 13, 2014
| 8:45 PM
WASHINGTON – Key elements of a new nuclear agreement between Iran and six world powers are contained in an informal, 30-page text not yet publicly acknowledged by Western officials, Iran’s chief negotiator said Monday.
| Apr 21, 2014
| 8:41 PM
Activist investor Bill Ackman is partnering with a Canadian pharmaceutical company in an effort to buy Allergan Inc., the Irvine company that makes the popular wrinkle treatment Botox.
Ackman and Valeant Pharmaceuticals International Inc. have already...
| Apr 22, 2014
| 7:33 PM
Canadian company Valeant Pharmaceuticals International Inc. and activist investor Bill Ackman moved forward with their plans to acquire Botox maker Allergan Inc., offering shareholders about $46 billion and touching off what could be a contentious fight....
| Apr 9, 2014
| 7:46 AM
Lupin Pharmaceuticals, Inc. has placed its name in lights over the Inner Harbor, a mark of the Indian drug manufacturer's growing presence since the company located its U.S. headquarters in Baltimore more than a decade ago.
Lupin, which today sells...
| Mar 24, 2014
| 3:00 AM
Earlier this General Assembly session, we joined together to announce a transformational economic development commission, a part of a joint economic development agenda that builds on the strategic investments Gov. Martin O'Malley and the legislature...